Concepedia

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

Anna S. Lok, David Gardiner, Christophe Hézode, Eric Lawitz, Marc Bourlière, Gregory T. Everson, Patrick Marcellin, M. Rodríguez‐Torres, Stanislas Pol, Lawrence Serfaty,

Journal of Hepatology · 2013 · 139 citations · 25 references

DOI

Concepts

References

25

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Dongliang Ge, Jacques Fellay, Alexander Thompson et al. · Nature · 2009 · 3.5K citations · Full text

, , +13

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Marc G. Ghany, Doris B. Strader, David L. Thomas et al. · Hepatology · 2008 · 3K citations · Full text

, , +17

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Joseph F. Perz, Gregory L. Armstrong, Leigh A. Farrington et al. · Journal of Hepatology · 2006 · 2.6K citations · Full text

, , +16

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

, , +17

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

, , +16